D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens

A. S. Keys, Gregory Mark

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

To assess the interaction of dopamine and acetylcholine systems in the rat nucleus accumbens in response to direct D-amphetamine administration, in vivo microdialysis measures of acetylcholine were used during reverse dialysis of amphetamine alone and in combination with D1 and D2 receptor antagonists SCH 23390 and sulpiride, respectively. During a 15-min exposure to amphetamine (50 μM) in the nucleus accumbens, acetylcholine increased to 33% above pre-infusion levels, became maximal at 15 min post-infusion (+41%) and gradually returned to baseline levels by 60 min post-amphetamine. Conversely, amphetamine (1 mM) administration caused a biphasic change in acetylcholine release with a trend toward a decrease (-14%) during exposure followed by a significant increase (+36%) at 30 min post-amphetamine that returned to baseline levels by 60 min after infusion. The increases observed during amphetamine (50 μM) exposure and during recovery from amphetamine (1 mM) were both blocked by co-administration with the D1 antagonist, SCH 23390 (10 μM), but not with the D2 antagonist, sulpiride (10 μM). Co-infusion of sulpiride eliminated the trend toward reduced acetylcholine release observed during 1 mM amphetamine whereas co-administration of SCH 23390 potentiated this decrease. A possible tonic D1 facilitation of nucleus accumbens acetylcholine release was indicated by the consistent reductions in acetylcholine release observed during infusion of SCH 23390. These results suggest that amphetamine administration in the nucleus accumbens induces a bidirectional change in acetylcholine release that is dependent on dose and opposing effects of nucleus accumbens D1 and D2 activation. In general, relatively low doses of amphetamine administered into the nucleus accumbens caused an increase in acetylcholine release that was dependent on dopamine D1 receptors whereas higher doses of amphetamine resulted in a D2-mediated decrease.

Original languageEnglish (US)
Pages (from-to)521-531
Number of pages11
JournalNeuroscience
Volume86
Issue number2
DOIs
StatePublished - Jun 1 1998

Fingerprint

Dopamine D1 Receptors
Dopamine D2 Receptors
Nucleus Accumbens
Amphetamine
Acetylcholine
Sulpiride
Microdialysis
Dialysis
Dopamine

Keywords

  • Microdialysis
  • Psychostimulant
  • Rat
  • Reverse dialysis
  • SCH 23390
  • Sulpiride

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens. / Keys, A. S.; Mark, Gregory.

In: Neuroscience, Vol. 86, No. 2, 01.06.1998, p. 521-531.

Research output: Contribution to journalArticle

@article{48d7bbe332bb42ebb9e05a792f533710,
title = "D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens",
abstract = "To assess the interaction of dopamine and acetylcholine systems in the rat nucleus accumbens in response to direct D-amphetamine administration, in vivo microdialysis measures of acetylcholine were used during reverse dialysis of amphetamine alone and in combination with D1 and D2 receptor antagonists SCH 23390 and sulpiride, respectively. During a 15-min exposure to amphetamine (50 μM) in the nucleus accumbens, acetylcholine increased to 33{\%} above pre-infusion levels, became maximal at 15 min post-infusion (+41{\%}) and gradually returned to baseline levels by 60 min post-amphetamine. Conversely, amphetamine (1 mM) administration caused a biphasic change in acetylcholine release with a trend toward a decrease (-14{\%}) during exposure followed by a significant increase (+36{\%}) at 30 min post-amphetamine that returned to baseline levels by 60 min after infusion. The increases observed during amphetamine (50 μM) exposure and during recovery from amphetamine (1 mM) were both blocked by co-administration with the D1 antagonist, SCH 23390 (10 μM), but not with the D2 antagonist, sulpiride (10 μM). Co-infusion of sulpiride eliminated the trend toward reduced acetylcholine release observed during 1 mM amphetamine whereas co-administration of SCH 23390 potentiated this decrease. A possible tonic D1 facilitation of nucleus accumbens acetylcholine release was indicated by the consistent reductions in acetylcholine release observed during infusion of SCH 23390. These results suggest that amphetamine administration in the nucleus accumbens induces a bidirectional change in acetylcholine release that is dependent on dose and opposing effects of nucleus accumbens D1 and D2 activation. In general, relatively low doses of amphetamine administered into the nucleus accumbens caused an increase in acetylcholine release that was dependent on dopamine D1 receptors whereas higher doses of amphetamine resulted in a D2-mediated decrease.",
keywords = "Microdialysis, Psychostimulant, Rat, Reverse dialysis, SCH 23390, Sulpiride",
author = "Keys, {A. S.} and Gregory Mark",
year = "1998",
month = "6",
day = "1",
doi = "10.1016/S0306-4522(98)00018-9",
language = "English (US)",
volume = "86",
pages = "521--531",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens

AU - Keys, A. S.

AU - Mark, Gregory

PY - 1998/6/1

Y1 - 1998/6/1

N2 - To assess the interaction of dopamine and acetylcholine systems in the rat nucleus accumbens in response to direct D-amphetamine administration, in vivo microdialysis measures of acetylcholine were used during reverse dialysis of amphetamine alone and in combination with D1 and D2 receptor antagonists SCH 23390 and sulpiride, respectively. During a 15-min exposure to amphetamine (50 μM) in the nucleus accumbens, acetylcholine increased to 33% above pre-infusion levels, became maximal at 15 min post-infusion (+41%) and gradually returned to baseline levels by 60 min post-amphetamine. Conversely, amphetamine (1 mM) administration caused a biphasic change in acetylcholine release with a trend toward a decrease (-14%) during exposure followed by a significant increase (+36%) at 30 min post-amphetamine that returned to baseline levels by 60 min after infusion. The increases observed during amphetamine (50 μM) exposure and during recovery from amphetamine (1 mM) were both blocked by co-administration with the D1 antagonist, SCH 23390 (10 μM), but not with the D2 antagonist, sulpiride (10 μM). Co-infusion of sulpiride eliminated the trend toward reduced acetylcholine release observed during 1 mM amphetamine whereas co-administration of SCH 23390 potentiated this decrease. A possible tonic D1 facilitation of nucleus accumbens acetylcholine release was indicated by the consistent reductions in acetylcholine release observed during infusion of SCH 23390. These results suggest that amphetamine administration in the nucleus accumbens induces a bidirectional change in acetylcholine release that is dependent on dose and opposing effects of nucleus accumbens D1 and D2 activation. In general, relatively low doses of amphetamine administered into the nucleus accumbens caused an increase in acetylcholine release that was dependent on dopamine D1 receptors whereas higher doses of amphetamine resulted in a D2-mediated decrease.

AB - To assess the interaction of dopamine and acetylcholine systems in the rat nucleus accumbens in response to direct D-amphetamine administration, in vivo microdialysis measures of acetylcholine were used during reverse dialysis of amphetamine alone and in combination with D1 and D2 receptor antagonists SCH 23390 and sulpiride, respectively. During a 15-min exposure to amphetamine (50 μM) in the nucleus accumbens, acetylcholine increased to 33% above pre-infusion levels, became maximal at 15 min post-infusion (+41%) and gradually returned to baseline levels by 60 min post-amphetamine. Conversely, amphetamine (1 mM) administration caused a biphasic change in acetylcholine release with a trend toward a decrease (-14%) during exposure followed by a significant increase (+36%) at 30 min post-amphetamine that returned to baseline levels by 60 min after infusion. The increases observed during amphetamine (50 μM) exposure and during recovery from amphetamine (1 mM) were both blocked by co-administration with the D1 antagonist, SCH 23390 (10 μM), but not with the D2 antagonist, sulpiride (10 μM). Co-infusion of sulpiride eliminated the trend toward reduced acetylcholine release observed during 1 mM amphetamine whereas co-administration of SCH 23390 potentiated this decrease. A possible tonic D1 facilitation of nucleus accumbens acetylcholine release was indicated by the consistent reductions in acetylcholine release observed during infusion of SCH 23390. These results suggest that amphetamine administration in the nucleus accumbens induces a bidirectional change in acetylcholine release that is dependent on dose and opposing effects of nucleus accumbens D1 and D2 activation. In general, relatively low doses of amphetamine administered into the nucleus accumbens caused an increase in acetylcholine release that was dependent on dopamine D1 receptors whereas higher doses of amphetamine resulted in a D2-mediated decrease.

KW - Microdialysis

KW - Psychostimulant

KW - Rat

KW - Reverse dialysis

KW - SCH 23390

KW - Sulpiride

UR - http://www.scopus.com/inward/record.url?scp=0032152895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032152895&partnerID=8YFLogxK

U2 - 10.1016/S0306-4522(98)00018-9

DO - 10.1016/S0306-4522(98)00018-9

M3 - Article

C2 - 9881866

AN - SCOPUS:0032152895

VL - 86

SP - 521

EP - 531

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 2

ER -